CorMedix Inc. (NASDAQ:CRMD) Q4 2018 Results Conference Call March 14, 2019 4:30 PM ET Company Participants Daniel Ferry - IR LifeSci Advisors Khoso Baluch - CEO Bob Cook - CFO Liz Masson - EVP and Head of Clinical Operations Paul Chew - Chief Medical Officer Conference Call Participants Ram Selvaraju - H.C. Wainwright Jerry Isaacson - ROTH Capital Operator Greetings, and welcome to CorMedix Fourth Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer s ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ Commission file number: 001-34673 CORMEDIX INC. (Exact name of Registrant as Specified in Its Charter) Delaware 2 ...